Navigation Links
Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
Date:3/17/2008

>

share $(2.13)

Shares used to compute basic

and diluted net loss per share 19,584

[1] Reflects operating results in accordance with U.S. generally accepted

accounting principles (or GAAP).

[2] Represents share-based compensation expense.

[3] Non-GAAP amounts exclude share-based compensation expense.

Alexza Pharmaceuticals, Inc.

(a development stage company)

Condensed Consolidated Balance Sheets

(in thousands)

December 31, December 31,

Assets 2007 2006

[1] [1]

Cash, cash equivalents and marketable

securities 69,391 42,623

Investments held by Symphony Allegro,

Inc. 39,449 49,956

Other current assets 13,432 1,263

Total current assets 122,272 93,842

Property and equipment, net 26,156 11,136

Other non-current assets 697 788

Total assets 149,125 105,766

Liabilities and stockholders' equity

Current liabilities 16,180 14,193

Non-current liabilities 33,002 7,056

Non-controlling interest in Symphony

Allegro, Inc. 23,952 34,743

Stockholders equity 75,991 49,774

Total liabilities and stockholders'

equity (deficit) 149,125
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , Oct. 20, 2014  Indianapolis interventional ... Toronto -based 3D visualization leader ... Congress of Neurological Surgeons Annual Meeting that they ... for brain surgery. The collaboration is the first ... combination to improve patient outcomes. NICO,s BrainPath® interventional ...
(Date:10/20/2014)... 20, 2014 Valeritas, Inc., a leader in ... with Type 2 diabetes, announced today that it has ... The award was presented October 16 th at ... Ohio . The Cardinal Health ... variety of metrics specifically targeted at the importance of ...
(Date:10/20/2014)... , Oct. 20, 2014   Taiho ... Co., Ltd. ( Japan ), announced ... granted Fast Track designation for TAS-102 (nonproprietary names: ... drug under investigation for the treatment of refractory ... has initiated a rolling NDA submission to the ...
Breaking Medicine Technology:Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4
... Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, ... treated with infliximab, a biologic therapy that has been used to ... diseases, including rheumatoid arthritis, Crohn,s disease and ulcerative colitis. , ... Human anti-chimeric antibody (HACA) ...
... May 13 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today it will be ... 2010 , at 8:45 a.m. Eastern Time .   , ... webcast of the presentation can be accessed via Zimmer,s Investor Relations website at http://investor.zimmer.com . ... , , About ...
Cached Medicine Technology:Prometheus Announces New Method for Real-Time Monitoring of Patients Treated With Biologic Therapy 2Zimmer Holdings to Present at Baird's 2010 Growth Stock Conference 2
(Date:10/20/2014)... 2014 ASCNYC (ascnyc.org) is a ... New Yorkers living with HIV/AIDS and other chronic ... recovery and self-sufficiency. Each year, ASCNYC spotlights selected ... through their tireless efforts. , Savills Studley ... has been selected as this year’s honoree for ...
(Date:10/20/2014)... Indianapolis, IN (PRWEB) October 20, 2014 ... Quick Start, a secure cloud solution that enables ... advantage of the ultimate healthcare-specific customer relationship management ... to meet the unique needs of the healthcare ... healthcare experience for providers and patients by combining ...
(Date:10/20/2014)... My Clients Plus ( http://www.MyClientsPlus.com ) ... The new module enables easy administration and routing of ... care. , This application allows users such as Therapists ... a to-do item to a specific client, categorize tasks ... reoccurring reminders for follow-ups. It's designed to enable ...
(Date:10/20/2014)... PA (PRWEB) October 20, 2014 ... Matthew Voicheck as Assistant Director of their ... role in managing the innovative turnkey drug sourcing, ... , Matthew brings over 12 years of industry ... joins Myoderm at the peak of their international ...
(Date:10/20/2014)... Collins, CO (PRWEB) October 20, 2014 ... dGH assays are the only imaging assays capable ... in a single test.  With these three dimensions ... their ability to detect the widest range of ... translocations—mutations usually missed by other genomic tools, including ...
Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3
... kidneys for transplantation. One solution is to increase the ... recent paper in the November issue of the journal ... strategies that have been developed to increase the number ... the adoption of these strategies at a single center. ...
... Italian epidemiologist as done a systematic review of various studies ... The study is focused to find out the link between ... believed that use of MMR vaccine shots in children’s may ... children around the world and concluded that MMR shots are ...
... characterized by progressive memory loss, decline in language skills ... to ageing population.// ,A recent paper in ... strategies in drug discovery. Hong-Yu Zhang, the author of ... one-drug-one-target strategy in drug discovery is limited, which has ...
... Acute ischemic stroke attributable to extracranial internal carotid artery ... death. // ,In selected cases, re-vascularization with carotid ... rate, and clinical outcomes in consecutive case series are ... a balloon-tipped catheter is inserted into an artery and ...
... Singh and Union Health Minister Anbumani Ramadoss are to convene ... problem of bird flu epidemic. //Awareness of bird flu and ... to the Western countries. The World Health Organization has sent ... if there are any possible flu attack. Dr. Anbumani said ...
... Professor Hans Theodor Eich and his colleagues from University ... radiation in Hodgkin’s Lymphoma patients undergoing chemotherapy does not ... reducing the side effects of radiation therapy. The results ... Therapeutic Radiology and Oncology. The researchers have reduced the ...
Cached Medicine News:Health News:Strategies To Boost Living Donor Kidney Transplants 2Health News:MMR Vaccination not linked to Autism 2
... addition to the Primus family of fine ... of speed and accuracy in a flexible ... testing. Test results in 2 minutes using ... lab or clinic., ,The PDQ system comes ...
Metrika's A1cNow Monitor is the first ever single-use test for hemoglobin A1c, it is the "gold standard" indicator of diabetes management. The test is easy to use, needs only a drop of blood and take...
... The intelligent CELL-DYN WorkCell delivers complete hematology ... operator safety. A modular configuration provides the ... basic system includes one Navigator module, one ... main bar code reader. The basic system ...
... The STart 4 semi-automated hemostasis ... of electro-mechanical clot detection (Viscosity-based Detection ... lipemic, icteric or other optically turbid ... analyzer offers programmable and preprogrammed assays ...
Medicine Products: